Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YPL209C | IPL1 | SGDID:S000006130 | DCLK1 DCAMKL1 DCDC3A KIAA0369 |
Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1) |
2.7.11.1 | Homo sapiens | Zellweger Syndrome,Colorectal Cancer,Attention Deficit-Hyperactivity Disorder,Chemical Colitis,Band Heterotopia |
5jzj_b | O15075 | ENSG00000133083 | DCLK1 | 99.30 | 4.70E-16 | 3.50E-20 | 138.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKCB PKCB PRKCB1 |
Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) |
2.7.11.13 | Homo sapiens | Severe Nonproliferative Diabetic Retinopathy,Hyperglycemia,Macroglobulinemia,Diabetic Macular Edema,Microvascular Complications Of Diabetes 5,Diabetes Mellitus,Macular Retinal Edema,B-Cell Lymphoma,Myotonic Dystrophy 1,Primary Biliary Cholangitis,Diabetic Neuropathy,Kidney Disease,Eye Disease,Glioblastoma,Hepatocellular Carcinoma,Type 2 Diabetes Mellitus,Leukemia, Chronic Lymphocytic,Autism,Lung Cancer |
2i0e_a | P05771 | ENSG00000166501 | PRKCB | 99.30 | 5.50E-16 | 4.00E-20 | 141.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | GSK3B |
Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) |
2.7.11.26 | Homo sapiens | Liver Disease,Endometrial Cancer,Epilepsy,Polycystic Kidney Disease,Diabetes Mellitus,Alzheimer Disease,Major Depressive Disorder,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Barbiturate Dependence,Alzheimer Disease 9,Dementia,Fallopian Tube Serous Adenocarcinoma,Breast Cancer,Parkinson Disease, Late-Onset,Colorectal Cancer,Parkinson Disease 1, Autosomal Dominant,Hepatocellular Carcinoma,Bipolar Disorder,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Type 2 Diabetes Mellitus,Schizophrenia,Ophthalmomyiasis,Familial Adenomatous Polyposis,Severe Congenital Neutropenia,Aneurysmal Bone Cysts,Attention Deficit-Hyperactivity Disorder,Medulloblastoma,Frontotemporal Dementia,Pancreatic Cancer |
1j1b_b | P49841 | ENSG00000082701 | GSK3B | 99.30 | 1.60E-16 | 1.10E-20 | 149.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PAK1 |
Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) |
2.7.11.1 | Homo sapiens | Thymic Neuroendocrine Tumor,Prolapse Of Urethra,Gastroesophageal Junction Adenocarcinoma,Neurofibromatosis,Breast Cancer,Colorectal Cancer,Gastric Cancer,Intellectual Developmental Disorder With Macrocephaly, Seizures, And Speech Delay,Helicobacter Pylori Infection |
5kbq_a | Q13153 | ENSG00000149269 | PAK1 | 99.30 | 6.80E-16 | 5.00E-20 | 136.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | aurkb-a airk2-a |
Aurora kinase B-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 2-A) (AIRK2-A) (XAIRK2-A) (Serine/threonine-protein kinase 12-A) (Serine/threonine-protein kinase aurora-B-A) (xAurora-B) |
2.7.11.1 | Xenopus laevis | 4c2v_b | Q6DE08 | 99.40 | 1.60E-17 | 1.20E-21 | 146.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | NEK1 KIAA1901 |
Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease,Uterine Adnexa Cancer,Cor Triatriatum,Cor Triatriatum Dexter,Amyotrophic Lateral Sclerosis 1,Short-Rib Thoracic Dysplasia 12,Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1,Lateral Sclerosis,Motor Neuron Disease,Nephronophthisis,Short-Rib Thoracic Dysplasia 3 With Or Without Polydactyly,Fundus Dystrophy,Kidney Disease,Ellis-Van Creveld Syndrome,Amyotrophic Lateral Sclerosis 24,Polydactyly,Mega-Corpus-Callosum Syndrome With Cerebellar Hypoplasia And Cortical Malformations,Cranioectodermal Dysplasia,Asphyxiating Thoracic Dystrophy,Weyers Acrofacial Dysostosis,Mohr Syndrome,Short-Rib Thoracic Dysplasia 1 With Or Without Polydactyly,Frontotemporal Dementia,Joubert Syndrome 1,Short-Rib Thoracic Dysplasia 6 With Or Without Polydactyly |
4apc_b | Q96PY6 | ENSG00000137601 | NEK1 | 99.30 | 5.20E-16 | 3.80E-20 | 141.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | SAPK10 |
SAPK10 |
Saccharum officinarum | 5wax_a | A0A238LNS4 | 99.30 | 4.70E-16 | 3.40E-20 | 139.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | ROCK2 KIAA0619 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Dextrocardia,Ureteral Obstruction,Breast Cancer,Tongue Squamous Cell Carcinoma,Hypertension, Essential |
4wot_b | O75116 | ENSG00000134318 | ROCK2 | 99.40 | 3.30E-17 | 2.40E-21 | 152.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKCH PKCL PRKCL |
Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) |
2.7.11.13 | Homo sapiens | Myofibrillar Myopathy,Amphetamine Abuse,Stroke, Ischemic,Glioblastoma |
3txo_a | P24723 | ENSG00000027075 | PRKCH | 99.40 | 3.50E-17 | 2.60E-21 | 149.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CDK5 CDKN5 |
Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) |
2.7.11.1 | Homo sapiens | Cerebellar Hypoplasia,Supranuclear Palsy, Progressive, 1,Polycystic Kidney Disease,Dyslexia,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Transient Cerebral Ischemia,Giant Axonal Neuropathy 2,Motor Neuron Disease,Neuroblastoma,Hereditary Spastic Paraplegia,Nephronophthisis,Alzheimer Disease 9,Scrapie,Parkinson Disease, Late-Onset,Lissencephaly With Cerebellar Hypoplasia,Pick Disease Of Brain,Ischemia,Developmental And Epileptic Encephalopathy 5,Disease Of Mental Health,Toxic Encephalopathy,Dementia, Lewy Body,Lissencephaly,Aneurysmal Bone Cysts,Lissencephaly 7 With Cerebellar Hypoplasia,Syndromic Intellectual Disability,Non-Syndromic Intellectual Disability,Multiple System Atrophy 1,Myasthenic Syndrome, Congenital, 19,Primary Autosomal Recessive Microcephaly,C Syndrome,Lung Cancer |
4au8_b | Q00535 | ENSG00000164885 | CDK5 | 99.30 | 5.00E-16 | 3.70E-20 | 137.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PKN1 PAK1 PKN PRK1 PRKCL1 |
Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) |
2.7.11.13 | Homo sapiens | 4otd_a | Q16512 | ENSG00000123143 | PKN1 | 99.30 | 1.40E-16 | 1.00E-20 | 145.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | ULK2 KIAA0623 |
Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) |
2.7.11.1 | Homo sapiens | 6qau_a | Q8IYT8 | ENSG00000083290 | ULK2 | 99.30 | 1.80E-16 | 1.30E-20 | 139.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | PLK3 CNK FNK PRK |
Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) |
2.7.11.21 | Homo sapiens | Breast Cancer |
4b6l_a | Q9H4B4 | ENSG00000173846 | PLK3 | 99.40 | 1.00E-17 | 7.50E-22 | 148.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CDC42BPB KIAA1124 |
Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) |
2.7.11.1 | Homo sapiens | Myotonic Dystrophy,Epidermolysis Bullosa Simplex, Dowling-Meara Type |
5ote_a | Q9Y5S2 | ENSG00000198752 | CDC42BPB | 99.30 | 2.20E-16 | 1.60E-20 | 148.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CASK LIN2 |
Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog) |
2.7.11.1 | Homo sapiens | Cask-Related Disorders,Cerebellar Hypoplasia,Constipation,Congenital Nystagmus,Pathologic Nystagmus,Neurofibromatosis, Type I,Fraser Syndrome 1,Cask Disorders,Cerebellar Disease,Dystonia,Glucosephosphate Dehydrogenase Deficiency,Lobular Neoplasia,X-Linked Intellectual Disability, Najm Type,Cask-Related Intellectual Disability,Microcephaly,Hypertonia,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Fg Syndrome 4,Helsmoortel-Van Der Aa Syndrome,Aland Island Eye Disease,Developmental And Epileptic Encephalopathy 8,Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia,Anemia, Nonspherocytic Hemolytic, Due To G6pd Deficiency,Coffin-Siris Syndrome 1,Early Infantile Epileptic Encephalopathy,Opitz-Kaveggia Syndrome,Pontocerebellar Hypoplasia,Autism,Cerebellar Hypoplasia/Atrophy, Epilepsy, And Global Developmental Delay,Peho Syndrome |
3c0g_b | O14936 | ENSG00000147044 | CASK | 99.30 | 4.80E-16 | 3.50E-20 | 142.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Bos taurus | 2uzv_a | P00517 | 99.40 | 6.30E-17 | 4.60E-21 | 147.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | GRK6 GPRK6 |
G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) |
2.7.11.16 | Homo sapiens | Whim Syndrome |
3nyn_b | P43250 | ENSG00000198055 | GRK6 | 99.30 | 4.30E-16 | 3.00E-20 | 152.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | STK4 KRS2 MST1 |
Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] |
2.7.11.1 | Homo sapiens | T-Cell Immunodeficiency, Recurrent Infections, And Autoimmunity With Or Without Cardiac Malformations,Myeloproliferative Syndrome, Transient,Lymphoproliferative Syndrome 2,Epidermodysplasia Verruciformis 1,Immunodeficiency 13,Prostate Cancer,Coronin-1a Deficiency,Wilson-Turner X-Linked Mental Retardation Syndrome,Lung Cancer |
3com_a | Q13043 | ENSG00000101109 | STK4 | 99.20 | 8.00E-16 | 5.90E-20 | 138.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | cgd7_1840 |
cgd7_1840 |
Cryptosporidium parvum | 3f3z_a | Q5CYL9 | 99.30 | 2.70E-16 | 2.00E-20 | 138.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | MASTL GW GWL THC2 |
Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) |
2.7.11.1 | Homo sapiens | Autosomal Thrombocytopenia With Normal Platelets,Sick Building Syndrome,Thrombocytopenia,Thrombocytopenia 2,Gray Platelet Syndrome,Ceroid Lipofuscinosis, Neuronal, 2 |
5loh_a | Q96GX5 | ENSG00000120539 | MASTL | 99.40 | 4.70E-17 | 3.40E-21 | 148.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | unc-43 K11E8.1 |
Calcium/calmodulin-dependent protein kinase type II (CaM kinase II) (EC 2.7.11.17) (Uncoordinated protein 43) |
2.7.11.17 | Caenorhabditis elegans | 2bdw_b | O62305 | 99.40 | 3.80E-17 | 2.80E-21 | 150.40 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 4pdp_a | P22216 | 99.40 | 3.30E-17 | 2.40E-21 | 149.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | PRKAA2 AMPK AMPK2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) |
2.7.11.27,2.7.11.31, | Homo sapiens | Hyperglycemia,Hypertrophic Cardiomyopathy,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Tuberous Sclerosis,Breast Cancer,Ischemia,Aromatase Deficiency,Peutz-Jeghers Syndrome,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome |
2h6d_a | P54646 | ENSG00000162409 | PRKAA2 | 99.50 | 6.10E-18 | 4.50E-22 | 148.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MELK KIAA0175 |
Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) |
2.7.10.2 | Homo sapiens | Colorectal Cancer |
5k00_a | Q14680 | ENSG00000165304 | MELK | 99.40 | 9.90E-18 | 7.30E-22 | 152.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MAP4K3 RAB8IPL1 |
Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) |
2.7.11.1 | Homo sapiens | Adult-Onset Still'S Disease |
5j5t_a | Q8IVH8 | ENSG00000011566 | MAP4K3 | 99.40 | 2.10E-17 | 1.50E-21 | 152.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CDPK1 |
CDPK1 |
Toxoplasma gondii | 5t6i_a | Q9BJF5 | 99.30 | 2.90E-16 | 2.10E-20 | 151.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | MARK1 KIAA1477 MARK |
Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) |
2.7.11.26 | Homo sapiens | Alzheimer Disease,Peutz-Jeghers Syndrome,Autism |
6c9d_a | Q9P0L2 | ENSG00000116141 | MARK1 | 99.40 | 7.80E-17 | 5.60E-21 | 153.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PLK4 SAK STK18 |
Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak) |
2.7.11.21 | Homo sapiens | Congenital Nervous System Abnormality,Autosomal Recessive Chorioretinopathy-Microcephaly Syndrome,Colorectal Cancer,Microcephaly,Seckel Syndrome,Microcephaly And Chorioretinopathy, Autosomal Recessive, 2,Isolated Growth Hormone Deficiency,Primary Autosomal Recessive Microcephaly,Joubert Syndrome 1,Isolated Growth Hormone Deficiency, Type Ia |
3cok_b | O00444 | ENSG00000142731 | PLK4 | 99.40 | 2.00E-17 | 1.50E-21 | 145.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PAK4 KIAA1142 |
Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
2j0i_a | O96013 | ENSG00000130669 | PAK4 | 99.30 | 3.30E-16 | 2.50E-20 | 140.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MAP3K8 COT ESTF |
Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2) |
2.7.11.25 | Homo sapiens | Indolent Plasma Cell Myeloma,Paronychia,Skin Lipoma,Rheumatoid Arthritis,Lung Cancer |
4y85_b | P41279 | ENSG00000107968 | MAP3K8 | 99.30 | 4.10E-16 | 3.00E-20 | 141.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CRK2 PK5 |
Cell division control protein 2 homolog (EC 2.7.11.22) (EC 2.7.11.23) (PfPK5) |
2.7.11.22,2.7.11.23, | Plasmodium falciparum | 1v0b_a | Q07785 | 99.20 | 8.20E-16 | 6.10E-20 | 135.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | TGRH88_017420 |
TGRH88_017420 |
Toxoplasma gondii | 3dxn_a | Q3HNM6 | 99.30 | 8.30E-17 | 6.10E-21 | 142.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | CIPK23 LKS1 PKS17 SnRK3.23 At1g30270 F12P21.6 |
CBL-interacting serine/threonine-protein kinase 23 (EC 2.7.11.1) (Protein LOW-K(+)-SENSITIVE 1) (SNF1-related kinase 3.23) (SOS2-like protein kinase PKS17) |
2.7.11.1 | Arabidopsis thaliana | 4czt_d | Q93VD3 | 99.30 | 9.90E-17 | 7.10E-21 | 153.00 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CPK2 CDPK2 |
Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2) |
2.7.11.1 | Plasmodium falciparum | 4mvf_a | O15865 | 99.30 | 3.30E-16 | 2.40E-20 | 150.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | PRKACA PKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fibrolamellar Carcinoma,Cardioacrofacial Dysplasia 1,Dilated Cardiomyopathy,Acth-Independent Cushing Syndrome,Osteoporosis,Breast Cancer,Pigmented Nodular Adrenocortical Disease, Primary, 4,Primary Pigmented Nodular Adrenocortical Disease |
3ama_a | P17612 | ENSG00000072062 | PRKACA | 99.30 | 1.20E-16 | 8.70E-21 | 146.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PLK1 PLK |
Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) |
2.7.11.21 | Homo sapiens | Breast Papillomatosis,Squamous Cell Carcinoma,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Gonococcal Keratitis,Leukemia, Acute Myeloid,Trichothiodystrophy 1, Photosensitive,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Lung Squamous Cell Carcinoma,Lymphoma, Non-Hodgkin, Familial,Dyskeratosis Congenita, Autosomal Dominant 3,Esophageal Cancer,Brain Glioma,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
2owb_a | P53350 | ENSG00000166851 | PLK1 | 99.30 | 1.80E-16 | 1.30E-20 | 144.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKG1 PRKG1B PRKGR1A PRKGR1B |
cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) |
2.7.11.12 | Homo sapiens | Myopathy,Impotence,Connective Tissue Disease,Diabetes Mellitus,Aortic Dissection,Alzheimer Disease,Familial Thoracic Aortic Aneurysm And Aortic Dissection,Cystic Fibrosis,Aortic Disease,Aortic Valve Disease 1,Heritable Thoracic Aortic Disease,Hemolytic Anemia,Non-Proliferative Fibrocystic Change Of The Breast,Aneurysm,Aortic Aneurysm, Familial Thoracic 8,Disease Of Mental Health,Pulmonary Hypertension,Body Mass Index Quantitative Trait Locus 11,Aortic Aneurysm,Loeys-Dietz Syndrome,Immune Deficiency Disease,Myelodysplastic Syndrome,Attention Deficit-Hyperactivity Disorder,Aortic Aneurysm, Familial Thoracic 1,Hypertension, Essential,Sexual Disorder |
6bg2_a | Q13976 | ENSG00000185532 | PRKG1 | 99.30 | 1.20E-16 | 9.00E-21 | 146.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MYLK4 SGK085 |
Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085) |
2.7.11.1 | Homo sapiens | Cardiomyopathy, Familial Restrictive, 2,Deafness, Autosomal Recessive 17,Deafness, Autosomal Recessive 14,Cardiomyopathy, Familial Restrictive, 3 |
2x4f_a | Q86YV6 | ENSG00000145949 | MYLK4 | 99.40 | 1.00E-17 | 7.30E-22 | 155.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PKMYT1 MYT1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) |
2.7.11.1 | Homo sapiens | 5vcy_a | Q99640 | ENSG00000127564 | PKMYT1 | 99.40 | 5.10E-17 | 3.70E-21 | 145.80 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | PLK2 SNK |
Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) |
2.7.11.21 | Homo sapiens | Epilepsy, Familial Temporal Lobe, 2 |
4i5p_a | Q9NYY3 | ENSG00000145632 | PLK2 | 99.40 | 1.50E-17 | 1.10E-21 | 149.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PTSG_10090 |
PTSG_10090 |
2.7.11.17 | Salpingoeca rosetta | 5ig1_b | F2UPG5 | 99.40 | 2.40E-17 | 1.80E-21 | 150.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | STK17B DRAK2 |
Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2) |
2.7.11.1 | Homo sapiens | Colon Squamous Cell Carcinoma |
3lm5_a | O94768 | ENSG00000081320 | STK17B | 99.30 | 3.00E-16 | 2.20E-20 | 142.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | AKT1 PKB RAC |
RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) |
2.7.11.1 | Homo sapiens | Adult Hepatocellular Carcinoma,Breast Papillomatosis,Esophageal Disease,Pancreatic Adenocarcinoma,Muscular Disease,Skin Melanoma,Liver Disease,Mitral Valve Disease,Heart Disease,Neurofibromatosis, Type Ii,Endometrial Cancer,Bile Duct Disease,Spinal Chordoma,Hepatopulmonary Syndrome,Squamous Cell Carcinoma,Pfeiffer Syndrome,Glucose Metabolism Disease,Childhood T-Cell Acute Lymphoblastic Leukemia,Hyperglycemia,Retinitis Pigmentosa,Thyroid Gland Cancer,Hair Disease,Macroglobulinemia,Lung Cancer Susceptibility 3,Kagami-Ogata Syndrome,Adenoid Cystic Carcinoma,Non-Alcoholic Fatty Liver Disease,Chordoma,Cowden Syndrome,Polycystic Kidney Disease,Microvascular Complications Of Diabetes 5,Suppression Of Tumorigenicity 12,Melanoma,Connective Tissue Disease,Ocular Hypertension,Leukemia, Chronic Myeloid,Overnutrition,Inherited Metabolic Disorder,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Adenoma,Spherocytosis, Type 5,Cowden Syndrome 1,Breast Juvenile Papillomatosis,Lipid Storage Disease,Peripheral Nervous System Neoplasm,Uterine Corpus Cancer,Connective Tissue Cancer,Bone Sarcoma,Hypertrophic Cardiomyopathy,Placental Choriocarcinoma,Leukocyte Disease,Clear Cell Renal Cell Carcinoma,Hyperostosis,Alzheimer Disease,Hepatoblastoma,Rasopathy,Nasopharyngeal Disease,Myocardial Infarction,Major Depressive Disorder,Bile Duct Cancer,Intestinal Benign Neoplasm,Stroke, Ischemic,Teeth Hard Tissue Disease,Amyotrophic Lateral Sclerosis 1,Malignant Ovarian Surface Epithelial-Stromal Neoplasm,Ovary Epithelial Cancer,T-Cell Lymphoblastic Leukemia/Lymphoma,Ocular Cancer,Amelogenesis Imperfecta,Retinal Cancer,Blood Platelet Disease,Biliary Tract Disease,Congenital Lipomatous Overgrowth, Vascular Malformations, And Epidermal Nevi,Infratentorial Cancer,Leptin Deficiency Or Dysfunction,Lymphatic System Disease,Neurofibromatosis, Type I,Insulin-Like Growth Factor I,Neuroblastoma,Colonic Benign Neoplasm,Subependymal Glioma,Blood Coagulation Disease,Benign Ependymoma,Pilocytic Astrocytoma,Diffuse Astrocytoma,Childhood Leukemia,Bile Duct Adenocarcinoma,Hemangioma Of Lung,Nevus, Epidermal,Distal Muscular Dystrophy With Anterior Tibial Onset,Retinal Vascular Disease,Psychotic Disorder,Leukemia, Acute Myeloid,Noonan Syndrome 1,Bone Marrow Cancer,Leber Plus Disease,Hemangioma,Leukemia, Acute Lymphoblastic,Cataract,Combined Immunodeficiency,Liver Cirrhosis,Pancreas Disease,Papilloma,Cardiovascular System Disease,Autonomic Nervous System Neoplasm,Kidney Cancer,Pleural Cancer,Basal Cell Nevus Syndrome,Cowden Syndrome 6,Bladder Cancer,Focal Segmental Glomerulosclerosis,Epithelial-Myoepithelial Carcinoma,Thymus Gland Disease,Brain Cancer,Colonic Disease,Lung Adenoma,Lung Oat Cell Carcinoma,Endometrial Adenocarcinoma,Oropharynx Cancer,Cervix Carcinoma,Ulcerative Colitis,Nervous System Disease,Osteoporosis,Anal Squamous Cell Carcinoma,Ovarian Cancer,Adenocarcinoma,Tuberous Sclerosis 2,In Situ Carcinoma,Tuberous Sclerosis,T-Cell Acute Lymphoblastic Leukemia,Eye Disease,Acute Megakaryocytic Leukemia,Breast Carcinoma In Situ,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Malignant Astrocytoma,Gliosarcoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Peripheral Nervous System Disease,Nervous System Cancer,Ovarian Serous Cystadenocarcinoma,Cystadenocarcinoma,Serous Cystadenocarcinoma,Gallbladder Cancer,Hepatocellular Carcinoma,Premature Menopause,Combined Hepatocellular Carcinoma And Cholangiocarcinoma,Skin Papilloma,Partial Third-Nerve Palsy,Neurilemmoma,Rhabdomyosarcoma,Ischemia,Tongue Disease,Chronic Granulomatous Disease,Thymoma,Thymus Cancer,Ovarian Disease,Noonan Syndrome With Multiple Lentigines,Polycystic Kidney Disease 1 With Or Without Polycystic Liver Disease,Teratoma,Bipolar Disorder,Macular Degeneration, Age-Related, 1,Immunodeficiency 14,Sarcoma,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Cone-Rod Dystrophy 2,Prostate Cancer,Disease Of Mental Health,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Proteus Syndrome,Cervical Cancer,Toxic Encephalopathy,Ovarian Cystadenocarcinoma,Body Mass Index Quantitative Trait Locus 11,Penile Disease,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Central Nervous System Cancer,Pulmonary Fibrosis, Idiopathic,Congenital Myasthenic Syndrome,Retinitis Pigmentosa 47,Respiratory System Disease,Integumentary System Disease,Skin Disease,Cervical Adenocarcinoma,Ovary Adenocarcinoma,Gastric Adenocarcinoma,Type 2 Diabetes Mellitus,Plasmacytoma,Cervical Squamous Cell Carcinoma,Lynch Syndrome,Hidradenoma,Lung Squamous Cell Carcinoma,Fragile X Syndrome,Thyroid Gland Follicular Carcinoma,Schizophrenia,Sensory System Disease,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Skeletal Muscle Cancer,Muscle Cancer,Small Cell Cancer Of The Lung,Immunodeficiency 36,Hypotrichosis 1,Exanthem,Esophageal Cancer,Severe Congenital Neutropenia,Respiratory System Benign Neoplasm,Reproductive Organ Benign Neoplasm,Gastrointestinal System Benign Neoplasm,Immune Deficiency Disease,Myelodysplastic Syndrome,Meningioma, Radiation-Induced,Wiskott-Aldrich Syndrome,X-Linked Monogenic Disease,Autosomal Genetic Disease,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Peripheral T-Cell Lymphoma,Tuberous Sclerosis 1,Hashimoto Thyroiditis,Gastrointestinal Stromal Tumor,Diabetic Encephalopathy,Tongue Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Huntington Disease,Renal Cell Carcinoma, Nonpapillary,Nasopharyngeal Carcinoma,Hypertension, Essential,Meningioma, Familial,Pre-Malignant Neoplasm,Lymphatic System Cancer,Ductal Carcinoma In Situ,Estrogen-Receptor Positive Breast Cancer,Cell Type Benign Neoplasm,Cardiovascular Organ Benign Neoplasm,Uterine Benign Neoplasm,Acquired Metabolic Disease,Kaposi Sarcoma,Colitis,Klippel-Trenaunay-Weber Syndrome,Gallbladder Disease,Leukemia, Chronic Lymphocytic,Amelogenesis Imperfecta, Type Ig,Systemic Lupus Erythematosus,Pelizaeus-Merzbacher Disease,Rett Syndrome,Myeloma, Multiple,Medulloblastoma,Spinal Disease,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lymphoproliferative Syndrome,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Oculoectodermal Syndrome,Osteogenic Sarcoma,Pancreatic Cancer |
4gv1_a | P31749 | ENSG00000142208 | AKT1 | 99.40 | 1.30E-17 | 9.40E-22 | 152.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKCQ PRKCT |
Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) |
2.7.11.13 | Homo sapiens | Inflammatory Bowel Disease 1,T-Cell Lymphoblastic Leukemia/Lymphoma,Crohn'S Disease,Breast Cancer,Gastrointestinal Stromal Tumor |
4ra5_a | Q04759 | ENSG00000065675 | PRKCQ | 99.30 | 1.10E-16 | 8.20E-21 | 145.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | ROCK2 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Bos taurus | 2f2u_b | Q28021 | 99.40 | 7.60E-18 | 5.50E-22 | 157.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CDKL2 |
Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE) |
2.7.11.22 | Homo sapiens | Papillary Serous Adenocarcinoma,Orofaciodigital Syndrome Vi |
4aaa_a | Q92772 | ENSG00000138769 | CDKL2 | 99.30 | 1.70E-16 | 1.30E-20 | 144.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PDPK1 PDK1 |
3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Noonan Syndrome 1,Esophageal Adenosquamous Carcinoma,Prostate Cancer,Tuberous Sclerosis 1,Lung Cancer |
1h1w_a | O15530 | ENSG00000140992 | PDPK1 | 99.40 | 4.20E-17 | 3.10E-21 | 144.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | SNF1 CAT1 CCR1 GLC2 PAS14 YDR477W D8035.20 |
Carbon catabolite-derepressing protein kinase (EC 2.7.11.1) (Sucrose nonfermentating protein 1) |
2.7.11.1 | Saccharomyces cerevisiae | 2fh9_a | P06782 | 99.40 | 4.30E-17 | 3.20E-21 | 143.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CDK7 CAK CAK1 CDKN7 MO15 STK1 |
Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Myofibrillar Myopathy,Cockayne Syndrome,Breast Cancer,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Xeroderma Pigmentosum, Complementation Group B |
1ua2_b | P50613 | ENSG00000134058 | CDK7 | 99.30 | 2.80E-16 | 2.10E-20 | 143.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | ROCK1 |
Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Ocular Hyperemia,Breast Cancer,Pediatric Osteosarcoma,Hutchinson-Gilford Progeria Syndrome,Tetralogy Of Fallot,Hypertension, Essential,Lung Cancer |
2v55_c | Q13464 | ENSG00000067900 | ROCK1 | 99.30 | 1.80E-16 | 1.30E-20 | 148.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | ULK3 |
Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) |
2.7.11.1 | Homo sapiens | 6fdy_u | Q6PHR2 | ENSG00000140474 | ULK3 | 99.30 | 1.80E-16 | 1.30E-20 | 139.20 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | PASK KIAA0135 |
PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Niemann-Pick Disease, Type C1 |
3dls_a | Q96RG2 | ENSG00000115687 | PASK | 99.30 | 4.00E-16 | 2.90E-20 | 141.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | cgd4_240 |
cgd4_240 |
Cryptosporidium parvum | 3eb0_a | A3FQN0 | 99.30 | 3.20E-16 | 2.30E-20 | 145.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | ULK1 KIAA0722 |
Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1) |
2.7.11.1 | Homo sapiens | Retinitis Pigmentosa,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Tuberous Sclerosis 2,Acute Laryngopharyngitis,Tuberous Sclerosis 1,Huntington Disease |
4wno_a | O75385 | ENSG00000177169 | ULK1 | 99.30 | 4.40E-16 | 3.20E-20 | 137.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Cricetulus griseus | 5n3j_a | P25321 | 99.30 | 8.40E-17 | 6.10E-21 | 147.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CDK16 PCTAIRE1 PCTK1 |
Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) |
2.7.11.22 | Homo sapiens | 5g6v_a | Q00536 | ENSG00000102225 | CDK16 | 99.20 | 7.80E-16 | 5.70E-20 | 139.30 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | CAMK4 CAMK CAMK-GR CAMKIV |
Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) |
2.7.11.17 | Homo sapiens | Lung Large Cell Carcinoma,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Crouzon Syndrome With Acanthosis Nigricans,Systemic Lupus Erythematosus,Gingival Fibromatosis |
2w4o_a | Q16566 | ENSG00000152495 | CAMK4 | 99.40 | 4.70E-17 | 3.40E-21 | 149.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | TTN |
Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14) |
2.7.11.1 | Homo sapiens | Muscular Disease,Heart Disease,Constrictive Pericarditis,Congenital Fiber-Type Disproportion,Mitral Valve Insufficiency,Aortic Valve Disease 2,Congenital Structural Myopathy,Myopathy,Amyloidosis,Cardiomyopathy, Dilated, 1e,Syncope,Myofibrillar Myopathy,Atrial Heart Septal Defect,Mitochondrial Dna Depletion Syndrome 12b,Childhood-Onset Progressive Contractures-Limb-Girdle Weakness-Muscle Dystrophy Syndrome,Emery-Dreifuss Muscular Dystrophy,Cortical Thymoma,Muscle Tissue Disease,Morvan'S Fibrillary Chorea,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Familial Isolated Dilated Cardiomyopathy,Rasopathy,Autosomal Dominant Distal Myopathy,Lung Large Cell Carcinoma,Myopathy, Distal, 1,Myositis,Myotonic Dystrophy 1,Systolic Heart Failure,Myopathy, Myofibrillar, 1,Diastolic Heart Failure,Autosomal Recessive Limb-Girdle Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a,Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2g,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2j,Muscular Atrophy,Tibial Muscular Dystrophy,Limb-Girdle Muscular Dystrophy,Arrhythmogenic Right Ventricular Dysplasia, Familial, 1,Epithelial Malignant Thymoma,Hyaline Body Myopathy,Isolated Elevated Serum Creatine Phosphokinase Levels,Noonan Syndrome 1,Newborn Respiratory Distress Syndrome,Thymus Clear Cell Carcinoma,Reducing Body Myopathy,Myocarditis,Atrial Standstill 1,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 10,Hereditary Proximal Myopathy With Early Respiratory Failure,Dilated Cardiomyopathy,Alcoholic Cardiomyopathy,Lmna-Related Dilated Cardiomyopathy,Thymus Gland Disease,Long Qt Syndrome,Cardiomyopathy, Dilated, 1dd,Heart Conduction Disease,Udd Distal Myopathy - Tibial Muscular Dystrophy,Muscular Dystrophy, Congenital, Lmna-Related,Neuropathy,Perinephritis,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Right Dominant Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Biventricular Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Left Dominant Form,Myopathy, Myofibrillar, 3,Sick Sinus Syndrome,Multiminicore Disease,Cardiomyopathy, Familial Hypertrophic, 4,Cardiomyopathy, Dilated, 1a,Congestive Heart Failure,Myopathy, Myofibrillar, 4,Left Ventricular Noncompaction 2,Foot Drop,Myopathy, Myofibrillar, 5,Rhabdomyosarcoma,Rigid Spine Muscular Dystrophy 1,Epidermolysis Bullosa Simplex With Muscular Dystrophy,Thymoma,Thymus Cancer,Dendritic Cell Thymoma,Respiratory Failure,Centronuclear Myopathy,Myopathy, Myofibrillar, 9, With Early Respiratory Failure,Cardiomyopathy, Dilated, 1g,Congenital Myasthenic Syndrome,Cardiomyopathy, Familial Hypertrophic, 9,Cardiomyopathy, Dilated, 1h,Orthostatic Intolerance,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Lung Squamous Cell Carcinoma,Restrictive Cardiomyopathy,Extrinsic Cardiomyopathy,Lambert-Eaton Myasthenic Syndrome,Arrhythmogenic Right Ventricular Cardiomyopathy,Brugada Syndrome,Muscle Hypertrophy,Salih Myopathy,Nonaka Myopathy,Primary Cutaneous Amyloidosis,Distal Arthrogryposis,Familial Atrial Fibrillation,Hypermethioninemia Due To Adenosine Kinase Deficiency,Atrioventricular Block,Third-Degree Atrioventricular Block,Barth Syndrome,Cardioneuromyopathy With Hyaline Masses And Nemaline Rods,Cardiomyopathy, Familial Hypertrophic, 1,Wolff-Parkinson-White Syndrome,Muscular Dystrophy-Dystroglycanopathy , Type C, 5,Intrinsic Cardiomyopathy,Peripartum Cardiomyopathy,Lipoprotein Quantitative Trait Locus,Atrial Fibrillation,Scoliosis,Muscular Dystrophy, Duchenne Type,Myopathy, Centronuclear, X-Linked,Cardiac Arrest,Inguinal Hernia,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 2,Myasthenia Gravis,Left Ventricular Noncompaction,Lethal Congenital Contracture Syndrome,Myopathy, Centronuclear, 2,Batten-Turner Congenital Myopathy,Miyoshi Muscular Dystrophy,Tibial Muscular Dystrophy, Tardive,Cardiomyopathy, Dilated, 1b |
1tki_b | Q8WZ42 | ENSG00000155657 | TTN | 99.40 | 2.00E-17 | 1.50E-21 | 149.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | Taok2 Tao2 |
Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) |
2.7.11.1 | Rattus norvegicus | 1u5r_b | Q9JLS3 | 99.30 | 1.10E-16 | 8.30E-21 | 146.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 |
Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Melanoma,Plasma Cell Neoplasm,Uterine Corpus Cancer,Atypical Teratoid Rhabdoid Tumor,Neuroblastoma,Childhood Malignant Schwannoma,Adult Malignant Schwannoma,Bladder Cancer,Laryngeal Squamous Cell Carcinoma,Tetraploidy,Ovarian Cancer,Prostate Neuroendocrine Neoplasm,Breast Cancer,Colorectal Cancer,Endometrial Serous Adenocarcinoma,Hepatocellular Carcinoma,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Cervical Cancer,Lynch Syndrome,Esophageal Cancer,Donohue Syndrome,Colorectal Adenocarcinoma,Myeloma, Multiple,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
3h10_a | O14965 | ENSG00000087586 | AURKA | 99.50 | 3.60E-18 | 2.60E-22 | 149.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PHKG1 PHKG |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26) |
2.7.11.1,2.7.11.19,2.7.11.26 | Oryctolagus cuniculus | 2phk_a | P00518 | 99.40 | 3.70E-17 | 2.80E-21 | 143.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C |
Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) |
2.7.11.24 | Homo sapiens | Liver Disease,Endometrial Cancer,Lung Cancer Susceptibility 3,Non-Alcoholic Fatty Liver Disease,Hepatitis C,Acantholytic Acanthoma,Leukemia, Chronic Myeloid,Diabetes Mellitus,Non-Alcoholic Steatohepatitis,Fatty Liver Disease,Alzheimer Disease,Epidermolysis Bullosa Simplex,Hepatitis,Colon Adenocarcinoma,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Hereditary Spastic Paraplegia,Leukemia, Acute Lymphoblastic,Ovarian Cancer,Burkitt Lymphoma,Breast Cancer,Glioblastoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Hepatocellular Carcinoma,Sarcoma,Fibrosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Rheumatoid Arthritis,Type 2 Diabetes Mellitus,Renal Fibrosis,Acute Promyelocytic Leukemia,Huntington Disease,Nasopharyngeal Carcinoma,Cardiomyopathy, Familial Hypertrophic, 25,Neu-Laxova Syndrome 1,Lung Cancer,Pancreatic Cancer |
2xrw_a | P45983 | ENSG00000107643 | MAPK8 | 99.30 | 2.60E-16 | 1.90E-20 | 145.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKAA1 AMPK1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) |
2.7.11.26,2.7.11.27,2.7.11.31 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fatty Liver Disease,Breast Cancer,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome,Lung Cancer |
4red_a | Q13131 | ENSG00000132356 | PRKAA1 | 99.40 | 3.80E-17 | 2.70E-21 | 149.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | Brsk2 Kiaa4256 Sada |
Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase SAD-A) |
2.7.11.26 | Mus musculus | 4ynz_b | Q69Z98 | 99.40 | 5.40E-17 | 3.90E-21 | 148.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CAMK1G CLICK3 VWS1 |
Calcium/calmodulin-dependent protein kinase type 1G (EC 2.7.11.17) (CaM kinase I gamma) (CaM kinase IG) (CaM-KI gamma) (CaMKI gamma) (CaMKIG) (CaMK-like CREB kinase III) (CLICK III) |
2.7.11.17 | Homo sapiens | 2jam_a | Q96NX5 | ENSG00000008118 | CAMK1G | 99.30 | 1.50E-16 | 1.10E-20 | 142.70 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | Camk1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Rattus norvegicus | 1a06_a | Q63450 | 99.90 | 1.10E-26 | 8.10E-31 | 210.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | ssp2 SPCC74.03c |
SNF1-like protein kinase ssp2 (EC 2.7.11.1) |
2.7.11.1 | Schizosaccharomyces pombe | 3h4j_b | O74536 | 99.40 | 3.40E-17 | 2.50E-21 | 149.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | RPS6KB1 STK14A |
Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) |
2.7.11.1 | Homo sapiens | Mitral Valve Disease,Retinitis Pigmentosa,Cowden Syndrome,Pyriform Sinus Cancer,Cowden Syndrome 1,Placental Choriocarcinoma,Uterus Perivascular Epithelioid Cell Tumor,Subependymal Glioma,Benign Ependymoma,Leukemia, Acute Myeloid,Nephronophthisis,Kidney Angiomyolipoma,Aortic Disease,Skin Amelanotic Melanoma,Ovarian Cancer,Tuberous Sclerosis 2,Tuberous Sclerosis,Breast Cancer,Glioblastoma,Colorectal Cancer,Hepatocellular Carcinoma,Rhabdomyosarcoma,Acute Laryngopharyngitis,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Diamond-Blackfan Anemia 20,Esophageal Cancer,Muscle Hypertrophy,Mantle Cell Lymphoma,Tuberous Sclerosis 1,Lymphangioleiomyomatosis,Leukodystrophy, Hypomyelinating, 12,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Pancreatic Cancer |
3wf7_a | P23443 | ENSG00000108443 | RPS6KB1 | 99.30 | 1.40E-16 | 1.00E-20 | 144.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CDKL1 |
Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE) |
2.7.11.22 | Homo sapiens | Fraser Syndrome 1 |
4agu_b | Q00532 | ENSG00000100490 | CDKL1 | 99.20 | 7.60E-16 | 5.60E-20 | 137.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | RPS6KA1 MAPKAPK1A RSK1 |
Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) |
2.7.11.1 | Homo sapiens | Tuberous Sclerosis 2,Tuberous Sclerosis,Cardiomyopathy, Familial Hypertrophic, 4,Disease Of Mental Health,Adrenal Cortical Adenocarcinoma,Dyskeratosis Congenita, Autosomal Dominant 3,Tuberous Sclerosis 1,Coffin-Lowry Syndrome,Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
4nif_d | Q15418 | ENSG00000117676 | RPS6KA1 | 99.30 | 3.20E-16 | 2.30E-20 | 142.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CDKL3 NKIAMRE |
Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE) |
2.7.11.22 | Homo sapiens | Orofaciodigital Syndrome Vi |
3zdu_a | Q8IVW4 | ENSG00000006837 | CDKL3 | 99.30 | 3.40E-16 | 2.50E-20 | 141.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | WNK3 KIAA1566 PRKWNK3 |
Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) |
2.7.11.1 | Homo sapiens | Bartter Disease,Renal Tubular Transport Disease,Pseudohypoaldosteronism,Agenesis Of The Corpus Callosum With Peripheral Neuropathy,Arthrogryposis, Distal, Type 3,Liddle Syndrome 1,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypertension, Essential,Syndromic X-Linked Intellectual Disability Siderius Type,Gitelman Syndrome |
5o2c_a | Q9BYP7 | ENSG00000196632 | WNK3 | 99.30 | 4.50E-16 | 3.30E-20 | 144.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CAMK2A CAMKA KIAA0968 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Kagami-Ogata Syndrome,Alzheimer Disease,Alacrima, Achalasia, And Mental Retardation Syndrome,Mental Retardation, Autosomal Dominant 53,Disease Of Mental Health,Mental Retardation, Autosomal Recessive 63,Attention Deficit-Hyperactivity Disorder,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Autism |
2vz6_b | Q9UQM7 | ENSG00000070808 | CAMK2A | 99.20 | 8.50E-16 | 6.20E-20 | 138.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CHEK1 CHK1 |
Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) |
2.7.11.1 | Homo sapiens | Tongue Carcinoma,Neuroblastoma,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Cerebellar Disease,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Retinoblastoma,Esophageal Cancer,Seckel Syndrome,Mantle Cell Lymphoma,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Ovarian Clear Cell Carcinoma,Autosomal Recessive Cerebellar Ataxia,Li-Fraumeni Syndrome,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer |
2e9v_b | O14757 | ENSG00000149554 | CHEK1 | 99.40 | 5.50E-17 | 4.10E-21 | 141.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CHEK2 CDS1 CHK2 RAD53 |
Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Adenoid Cystic Carcinoma,Cowden Syndrome,Cervical Adenoma Malignum,Leiomyosarcoma,Bilateral Breast Cancer,B-Lymphoblastic Leukemia/Lymphoma,Diffuse Midline Glioma, H3 K27m-Mutant,Essential Thrombocythemia,Congenital Heart Defects, Multiple Types, 3,Familial Colorectal Cancer,Leukemia,Inherited Cancer-Predisposing Syndrome,Wilms Tumor 5,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Li-Fraumeni Syndrome 1,Telangiectasis,Basal Cell Carcinoma,Lung Leiomyosarcoma,Prostate Leiomyosarcoma,Cerebellar Disease,Bile Duct Cystadenoma,T-Cell Prolymphocytic Leukemia,Nk-Cell Enteropathy,Ovarian Cancer,Breast Cancer,Hereditary Breast Ovarian Cancer Syndrome,Colorectal Cancer,Li-Fraumeni Syndrome 2,Premature Menopause,Rhabdomyosarcoma,Xeroderma Pigmentosum, Variant Type,Sarcoma,Fanconi Anemia, Complementation Group A,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Thrombocytopenia,Lynch Syndrome,Esophageal Cancer,Seckel Syndrome,Myelodysplastic Syndrome,Gastric Cancer, Hereditary Diffuse,Tumor Predisposition Syndrome,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Wilms Tumor 1,Autosomal Recessive Cerebellar Ataxia,Lymphoma,Nijmegen Breakage Syndrome,Colitis,Li-Fraumeni Syndrome,Premature Ovarian Failure 1,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1,Lung Cancer,Osteogenic Sarcoma |
3i6u_a | O96017 | ENSG00000183765 | CHEK2 | 99.30 | 3.40E-16 | 2.50E-20 | 147.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PRKCI DXS1179E |
Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) |
2.7.11.13 | Homo sapiens | Glioblastoma,Lung Squamous Cell Carcinoma,Lung Cancer |
5li9_a | P41743 | ENSG00000163558 | PRKCI | 99.20 | 8.00E-16 | 5.80E-20 | 140.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | DMPK DM1PK MDPK |
Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) |
2.7.11.1 | Homo sapiens | Muscular Disease,Fuchs' Endothelial Dystrophy,Myopathy,Muscle Tissue Disease,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Myotonic Disease,Myotonic Dystrophy 1,Muscular Dystrophy,Myotonic Dystrophy,Spinocerebellar Ataxia 8,Myotonic Cataract,Cataract,Oculopharyngeal Muscular Dystrophy,Hair Follicle Neoplasm,Myotonic Dystrophy 2,Myotonia,Immature Cataract,Lens Disease,Autosomal Dominant Cerebellar Ataxia,Disease Of Mental Health,Fragile X Syndrome,Huntington Disease-Like 2,First-Degree Atrioventricular Block,Fragile X-Associated Tremor/Ataxia Syndrome,X-Linked Hereditary Ataxia,Spinal And Bulbar Muscular Atrophy, X-Linked 1,Catecholaminergic Polymorphic Ventricular Tachycardia,Frontotemporal Dementia,3-Methylglutaconic Aciduria, Type Iii |
2vd5_a | Q09013 | ENSG00000104936 | DMPK | 99.30 | 3.80E-16 | 2.80E-20 | 146.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | PKH2 PKH1 CAALFM_C112410CA CaO19.12690 CaO19.5224 orf19.5224 |
Serine/threonine-protein kinase PKH2 (EC 2.7.11.1) (PKB-activating kinase homolog 2) |
2.7.11.1 | Candida albicans | 4c0t_a | Q5A3P6 | 99.30 | 9.60E-17 | 6.60E-21 | 161.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | SRK2E OST1 SNRK2.6 At4g33950 F17I5.140 |
Serine/threonine-protein kinase SRK2E (EC 2.7.11.1) (Protein OPEN STOMATA 1) (SNF1-related kinase 2.6) (SnRK2.6) (Serine/threonine-protein kinase OST1) |
2.7.11.1 | Arabidopsis thaliana | 3udb_d | Q940H6 | 99.30 | 5.60E-16 | 4.10E-20 | 139.60 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | DAPK3 ZIPK |
Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) |
2.7.11.1 | Homo sapiens | Recessive Dystrophic Epidermolysis Bullosa |
1yrp_a | O43293 | ENSG00000167657 | DAPK3 | 99.30 | 1.20E-16 | 8.80E-21 | 140.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CSNK2A2 CK2A2 |
Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Connective Tissue Disease,Neonatal Leukemia,Distal Muscular Dystrophy With Anterior Tibial Onset,Spermatogenic Failure 50,Breast Adenocarcinoma,Theileriasis,Spermatogenic Failure 9 |
6hmq_a | P19784 | ENSG00000070770 | CSNK2A2 | 99.30 | 1.30E-16 | 9.70E-21 | 146.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | DAPK1 DAPK |
Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Childhood Acute Lymphocytic Leukemia,Lung Cancer Susceptibility 3,Adenoid Cystic Carcinoma,Cholecystitis,Alzheimer Disease,B-Cell Lymphoma,Mixed Oligodendroglioma-Astrocytoma,Transitional Cell Carcinoma,Bladder Cancer,Tuberous Sclerosis 2,Parkinson Disease, Late-Onset,Colorectal Cancer,Pediatric Lymphoma,Oligodendroglioma,Central Neurocytoma,Ischemia,Gastric Cancer,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Cervical Cancer,Cervical Squamous Cell Carcinoma,Myelodysplastic Syndrome,Nasopharyngeal Carcinoma,Lung Cancer |
2w4k_a | P53355 | ENSG00000196730 | DAPK1 | 99.30 | 3.40E-16 | 2.50E-20 | 139.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CAMK1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Homo sapiens | Acrofacial Dysostosis 1, Nager Type |
4fg7_a | Q14012 | ENSG00000134072 | CAMK1 | 99.30 | 8.70E-17 | 6.40E-21 | 143.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CPK4 CDPK4 PF07_0072 |
Calcium-dependent protein kinase 4 (EC 2.7.11.1) |
2.7.11.1 | Plasmodium falciparum | 4rgj_a | Q8IBS5 | 99.30 | 9.40E-17 | 6.90E-21 | 154.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | MAP3K5 ASK1 MAPKKK5 MEKK5 |
Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) |
2.7.11.25 | Homo sapiens | Liver Disease,Non-Alcoholic Fatty Liver Disease,Pyriform Sinus Cancer,Fatty Liver Disease,Alzheimer Disease,Glottis Squamous Cell Carcinoma,Partial Third-Nerve Palsy,Neural Tube Defects,Huntington Disease |
5uox_a | Q99683 | ENSG00000197442 | MAP3K5 | 99.30 | 5.20E-16 | 3.80E-20 | 135.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | EIF2AK3 PEK PERK |
Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) |
2.7.11.1 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Neonatal Diabetes,Prion Disease,Diabetes Mellitus,Alzheimer Disease,Rasopathy,Retinal Degeneration,Subungual Glomus Tumor,Crisponi/Cold-Induced Sweating Syndrome 1,Osteoporosis,Wolfram Syndrome,Epiphyseal Dysplasia, Multiple, With Early-Onset Diabetes Mellitus,Disease Of Mental Health,Leukoencephalopathy With Vanishing White Matter,Odontochondrodysplasia,Trichothiodystrophy 5, Nonphotosensitive,Cardiomyopathy, Familial Hypertrophic, 25,Permanent Neonatal Diabetes Mellitus,Palmoplantar Keratoderma, Bothnian Type |
4x7k_a | Q9NZJ5 | ENSG00000172071 | EIF2AK3 | 99.30 | 5.40E-16 | 4.00E-20 | 138.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | ROP5B ROP5 TGRH88_057710 |
ROP5B ROP5 TGRH88_057710 |
Toxoplasma gondii | 4lv5_a | F2YGR7 | 99.20 | 7.60E-16 | 5.50E-20 | 141.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | OXSR1 KIAA1101 OSR1 |
Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) |
2.7.11.1 | Homo sapiens | Bartter Disease,Arthrogryposis, Distal, Type 3,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypomagnesemia 3, Renal |
2vwi_c | O95747 | ENSG00000172939 | OXSR1 | 99.30 | 4.70E-16 | 3.50E-20 | 138.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | GRK5 GPRK5 |
G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) |
2.7.11.16 | Homo sapiens | Systolic Heart Failure,Palmoplantar Keratoderma And Congenital Alopecia 2,Asthma |
4tnd_a | P34947 | ENSG00000198873 | GRK5 | 99.30 | 4.80E-16 | 3.40E-20 | 152.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | Rop2 |
Rop2 |
Toxoplasma gondii | 3dzo_a | Q06AK3 | 99.30 | 2.00E-16 | 1.40E-20 | 148.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | SRK2I 41K OSKL2 SNRK2.3 At5g66880 MUD21.14 |
Serine/threonine-protein kinase SRK2I (EC 2.7.11.1) (OST1-kinase-like 2) (Protein ATHPROKIN B) (SNF1-related kinase 2.3) (SnRK2.3) |
2.7.11.1 | Arabidopsis thaliana | 3uc3_a | Q39193 | 99.30 | 8.80E-17 | 6.40E-21 | 147.70 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | MAP4K1 HPK1 |
Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) |
2.7.11.1 | Homo sapiens | 6cqd_b | Q92918 | ENSG00000104814 | MAP4K1 | 99.30 | 1.10E-16 | 8.40E-21 | 142.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YPL209C | IPL1 | SGDID:S000006130 | ROP8 |
ROP8 |
Toxoplasma gondii | 3byv_a | O15693 | 99.30 | 1.20E-16 | 9.00E-21 | 147.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YPL209C | IPL1 | SGDID:S000006130 | PHKG2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) |
2.7.11.19 | Homo sapiens | Glycogen Storage Disease Ixa,Glycogen Storage Disease Ixc,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency,Glycogen Storage Disease Ia,Glycogen Storage Disease, Type Ixd,Glycogen Storage Disease Ix,Glycogen Storage Disease Ixb |
2y7j_c | P15735 | ENSG00000156873 | PHKG2 | 99.50 | 5.20E-18 | 3.80E-22 | 156.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | RPS6KA3 ISPK1 MAPKAPK1B RSK2 |
Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
2.7.11.1 | Homo sapiens | Ventricular Septal Defect,Learning Disability,Symptomatic Form Of Coffin-Lowry Syndrome In Female Carriers,Cohen Syndrome,Specific Learning Disability,Gastroesophageal Reflux,Breast Cancer,Cardiomyopathy, Familial Hypertrophic, 4,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Chromosome 16p13.3 Deletion Syndrome, Proximal,Orthostatic Intolerance,Dyskeratosis Congenita, Autosomal Dominant 3,X-Linked Monogenic Disease,Non-Syndromic X-Linked Intellectual Disability,Coffin-Lowry Syndrome,Hypertelorism,Partington X-Linked Mental Retardation Syndrome,Scoliosis |
4d9u_a | P51812 | ENSG00000177189 | RPS6KA3 | 99.30 | 3.20E-16 | 2.30E-20 | 142.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | CAMK2D CAMKD |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1dd |
2vn9_a | Q13557 | ENSG00000145349 | CAMK2D | 99.30 | 2.50E-16 | 1.80E-20 | 140.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | Camk2d Kiaa4163 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Mus musculus | 6bab_a | Q6PHZ2 | 99.30 | 3.40E-16 | 2.50E-20 | 139.90 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CAMKK2 CAMKKB KIAA0787 |
Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) |
2.7.11.17 | Homo sapiens | Parkinson Disease, Late-Onset |
5uy6_a | Q96RR4 | ENSG00000110931 | CAMKK2 | 99.20 | 7.60E-16 | 5.60E-20 | 136.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | SNRK KIAA0096 SNFRK |
SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase) |
2.7.11.1 | Homo sapiens | Breast Angiosarcoma,Skin Angiosarcoma,Liver Angiosarcoma,Skin Sarcoma,Lymphangiosarcoma,Breast Sarcoma,Hydrolethalus Syndrome 1,Neuronopathy, Distal Hereditary Motor, Type Viii |
5yks_b | Q9NRH2 | ENSG00000163788 | SNRK | 99.30 | 1.50E-16 | 1.10E-20 | 147.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | nahK lnpB BLLJ_1622 |
N-acetylhexosamine 1-kinase (EC 2.7.1.162) (N-acetylgalactosamine/N-acetylglucosamine 1-kinase) |
2.7.1.162 | Bifidobacterium longum | 4wh3_a | E8MF12 | 99.40 | 2.60E-17 | 1.90E-21 | 150.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | CDKL5 STK9 |
Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) |
2.7.11.22 | Homo sapiens | Cdkl5 Deficiency Disorder,Ohtahara Syndrome,Seizure Disorder,Childhood Absence Epilepsy,Epilepsy,Gait Apraxia,Gene Duplication Disease,Nicolaides-Baraitser Syndrome,Amyotrophic Lateral Sclerosis 1,Angelman Syndrome,Focal Epilepsy,Developmental And Epileptic Encephalopathy 14,Epilepsy With Generalized Tonic-Clonic Seizures,Congenital Nervous System Abnormality,Developmental And Epileptic Encephalopathy,Fundus Dystrophy,Juvenile Retinoschisis,Bruxism,X-Linked Congenital Retinoschisis,Early Myoclonic Encephalopathy,Stxbp1 Encephalopathy,Microcephaly,Mental Retardation, Autosomal Dominant 20,Encephalopathy,Benign Neonatal Seizures,Alacrima, Achalasia, And Mental Retardation Syndrome,Benign Epilepsy With Centrotemporal Spikes,Developmental And Epileptic Encephalopathy 9,Methylmalonic Acidemia,Benign Familial Neonatal Epilepsy,West Syndrome,Disease Of Mental Health,Lubs X-Linked Mental Retardation Syndrome,Fragile X Syndrome,Pitt-Hopkins Syndrome,Mowat-Wilson Syndrome,Developmental And Epileptic Encephalopathy 2,Lennox-Gastaut Syndrome,Sturge-Weber Syndrome,Neonatal Period Electroclinical Syndrome,Infancy Electroclinical Syndrome,Childhood Electroclinical Syndrome,Early Infantile Epileptic Encephalopathy,Developmental And Epileptic Encephalopathy 4,Myasthenic Syndrome, Congenital, 11, Associated With Acetylcholine Receptor Deficiency,Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1,Aicardi Syndrome,Specific Developmental Disorder,Pervasive Developmental Disorder,Dravet Syndrome,Developmental And Epileptic Encephalopathy 1,Benign Familial Infantile Epilepsy,Generalized Epilepsy With Febrile Seizures Plus,Pyruvate Dehydrogenase E1-Alpha Deficiency,Retinoschisis 1, X-Linked, Juvenile,Rett Syndrome,Epilepsy, Myoclonic Juvenile,Autism,Christianson Syndrome,Epilepsy, Idiopathic Generalized,Peho Syndrome |
4bgq_a | O76039 | ENSG00000008086 | CDKL5 | 99.30 | 8.40E-17 | 6.30E-21 | 143.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MARK3 CTAK1 EMK2 |
MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) |
2.7.11.1 | Homo sapiens | Focal Epithelial Hyperplasia,Osteoporosis,Peutz-Jeghers Syndrome,Gaucher Disease, Type Iii,Visual Impairment And Progressive Phthisis Bulbi |
2qnj_b | P27448 | ENSG00000075413 | MARK3 | 99.40 | 1.70E-17 | 1.30E-21 | 150.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | MAP2K1 MEK1 PRKMK1 |
Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) |
2.7.12.2 | Homo sapiens | Melorheostosis, Isolated,Skin Melanoma,Achondroplasia,Heart Disease,Ichthyosis,Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Lung Cancer Susceptibility 3,Melorheostosis,Pulmonary Valve Stenosis,Suppression Of Tumorigenicity 12,Melanoma,Acneiform Dermatitis,Neurofibromatosis-Noonan Syndrome,Hypertrophic Cardiomyopathy,Osteopoikilosis,Alzheimer Disease,Rasopathy,Noonan Syndrome-Like Disorder With Loose Anagen Hair,Keratosis Pilaris Atrophicans Faciei,Costello Syndrome,Anthrax Disease,Extracranial Arteriovenous Malformation,Neurofibromatosis, Type I,Neuroblastoma,Skin Granular Cell Tumor,Pseudo-Turner Syndrome,Leukemia, Acute Myeloid,Noonan Syndrome 1,Senile Angioma,Hemangioma,Rosai-Dorfman Disease,Bladder Cancer,Mixed Cell Adenoma,Hairy Cell Leukemia,Prostate Squamous Cell Carcinoma,Noonan Syndrome-Like Disorder With Loose Anagen Hair 2,Cardiofaciocutaneous Syndrome 3,Ovarian Cancer,Myeloid Leukemia,Adenocarcinoma,Breast Cancer,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Pulmonary Valve Disease,Hepatocellular Carcinoma,Cardiofaciocutaneous Syndrome 1,Splenic Diffuse Red Pulp Small B-Cell Lymphoma,Pheochromocytoma,Rhabdomyosarcoma,Noonan Syndrome With Multiple Lentigines,Fibrosarcoma,Histiocytosis,Skin Carcinoma,Gastric Cancer,Arteriovenous Malformation,Prostate Cancer,Disease Of Mental Health,Gastric Adenocarcinoma,Langerhans Cell Histiocytosis,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Diamond-Blackfan Anemia 20,Acute Promyelocytic Leukemia,Ovarian Melanoma,Autism Spectrum Disorder,Kaposi Sarcoma,Cardiomyopathy, Familial Hypertrophic, 25,Medulloblastoma,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lung Cancer,Pancreatic Cancer |
3sls_b | Q02750 | ENSG00000169032 | MAP2K1 | 99.30 | 4.90E-16 | 3.60E-20 | 138.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YPL209C | IPL1 | SGDID:S000006130 | unc-22 ZK617.1 |
Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) |
2.7.11.1 | Caenorhabditis elegans | 3uto_a | Q23551 | 99.30 | 3.60E-16 | 2.60E-20 | 152.50 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YPL209C | IPL1 | SGDID:S000006130 | DYRK2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) |
2.7.12.1 | Homo sapiens | 4azf_a | Q92630 | ENSG00000127334 | DYRK2 | 99.40 | 4.60E-17 | 3.30E-21 | 153.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |